Brain Tumor Patient-Caregiver Congruence, MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT)

NCT00748774 | Completed

• 1 other identifier: 2008-0117
• Study Type: observational
• Target: 115
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this study is to compare patient ratings of how severe their own symptoms may be, with their caregivers' ratings of how severe they think the patients' symptoms may be. This will be compared using a questionnaire that is given to patients with brain tumors and their caregivers. Researchers will also study any effects that these patients' neurocognitive function may have on these patients' and their caregivers' ratings of how severe the brain cancer symptoms may be.

Conditions

Brain Tumor

Keywords

Primary Brain Tumor; Caregivers; Symptom Severity; Questionnaire; M.D. Anderson Symptom Inventory-Brain Tumor; MDASI-BT

Outcome Measures

Primary Outcomes (1)

• Mean Caregiver Ratings of Symptom Severity (using the mean of all the items from the MDASI-BT) in Patient-Caregiver Dyads

  Participant involvment is 10 minutes to complete MDASI-BT questionnaire

Study Arms (1)

MDASI-BT

MD Anderson Symptom Inventory-Brain Tumor (MDASI-BT) questionnaire given to patients with a primary brain tumor and their caregivers.

Behavioral: Questionnaire

Interventions

Questionnaire BEHAVIORAL

Two questionnaires taking about 10 minutes to complete.

Also known as: Survey

MDASI-BT

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Individuals with a brain tumor who are going to have neurocognitive testing as part of routine care and their caregivers.

You may qualify if:

• Imaging consistent with a primary brain tumor or prior pathologic diagnosis of primary brain tumor
• Referred for neurocognitive function testing as part of the plan of care
• Age \> or = 18 years of age
• Ability to speak, read, and write the English language
• Caregiver Attribute: Identified by the patient as being primarily involved in the patients' care in the home setting (biologic, legal, or functional relationship)
• Caregiver Attribute: Able to speak, read, and write the English language
• Both patient and caregiver have to agree to participate
• The caregiver needs to be present at the time the patient is recruited

You may not qualify if:

• Patients less than 18 years of age will be excluded from this study.
• Patients will be excluded from the study if they are unable to complete the self-report questionnaire or participate in neurocognitive testing.

Sponsors & Collaborators

• M.D. Anderson Cancer Center: lead

Study Sites (1)

University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

• University of Texas MD Anderson Cancer Center Website

MeSH Terms

Conditions

Brain Neoplasms

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Central Nervous System Neoplasms; Nervous System Neoplasms; Neoplasms by Site; Neoplasms; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Mark R. Gilbert, MD

  M.D. Anderson Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 5, 2008
• First Posted: September 9, 2008
• Study Start: May 1, 2008
• Primary Completion: September 1, 2014
• Study Completion: September 1, 2014
• Last Updated: January 7, 2016

Record last verified: 2016-01

Locations

US (1)